Covered recipient · General Payments record
ALEX DIMITRIU
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2024
$2,795.83
- Reported across 172 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $321.57 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $177.32 | 13 |
| Takeda Pharmaceuticals U.S.A., Inc. | $57.32 | 2 |
| Axsome Therapeutics, Inc. | $56.32 | 2 |
| Corium, Inc. | $30.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.64 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103643538 | CMS |
| ABBVIE INC. | $3.22 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103643540 | CMS |
| ABBVIE INC. | $17.10 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103643542 | CMS |
| ABBVIE INC. | $7.62 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103643544 | CMS |
| ABBVIE INC. | $25.67 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103643546 | CMS |
| ABBVIE INC. | $26.31 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103643548 | CMS |
| ABBVIE INC. | $24.47 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103643550 | CMS |
| ABBVIE INC. | $7.17 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103643552 | CMS |
| ABBVIE INC. | $22.19 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103643554 | CMS |
| ABBVIE INC. | $8.64 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103643556 | CMS |
| ABBVIE INC. | $15.80 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103643558 | CMS |
| ABBVIE INC. | $7.88 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103643560 | CMS |
| ABBVIE INC. | $3.61 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103643562 | CMS |
| Axsome Therapeutics, Inc. | $22.31 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148262391 | CMS |
| Axsome Therapeutics, Inc. | $34.01 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148262393 | CMS |
| Corium, LLC | $30.61 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100201622 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.08 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137531701 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.24 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137531705 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.